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Background: The number of nurses able to independently prescribe medicines in
England has risen steadily in recent years.
Aim: To evaluate the adequacy of nurses’ educational preparation for independent
prescribing and to describe nurses’ experiences of their continuing professional
development as prescribers in practice.
Design and method: Postal questionnaire survey.
Participants: Random sample of 246 nurses registered as nurse independent pre-
scribers with the Nursing and Midwifery Council.
Results: The majority of nurses considered that the initial taught course element of
their education programme met their needs, either to some extent (61% 151/246),
or completely (22% 54/246). Most nurses (77% 190/246) received the specified 12
days support from their supervising medical practitioner and most were satisfied
and positive about this experience. Nearly all of the nurses (>95%) reported that
they were able to maintain a range of specified prescribing competencies in6 Elsevier Ltd. All rights reserved.
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686 S. Latter et al.practice. Two thirds (62% 152/246) of the sample reported that they were receiving
support/supervision for prescribing. Ninety five per cent (233/246) of the sample
also reported that they engaged in self-directed informal continuing professional
development, but only half of the sample had experience of formally provided pro-
fessional development opportunities. Approximately half (52% 127/246) of the sam-
ple identified needs for continuing professional development.
Conclusion: This first national survey of the education and professional develop-
ment experiences of nurse independent prescribers in England provides evidence
which highlights areas in which national policy is working well, and also points up
issues which may need addressing as the roll out of nurse prescribing continues.
The study also highlights characteristics and issues that health care policy makers
and nurse educationalists internationally may wish to consider in developing and
refining their own nurse prescriber education programmes.c 2006 Elsevier Ltd. All rights reserved.Introduction
In recent years in England, legislative authority to
independently prescribe medicines has been ex-
tended to nurses working in a variety of clinical set-
tings as part of the drive to modernize health care
and make quality services accessible to all patients.
Since 2002, nurses have been able to access a Nurs-
ing andMidwifery Council (NMC) approvededucation
programme to prepare them to independently pre-
scribe a specified range of medicines from the Nurse
Prescribers’ Extended Formulary (NPEF).6 In Novem-
ber 2005, the Department of Health in England an-
nounced that, from spring 2006, appropriately
qualified nurses andpharmacistswill be able to inde-
pendently prescribe all licensed drugs, with the
exception of some controlled drugs. This represents
one of the most extensive developments of non-
medical prescribing anywhere in theworld. But until
recently, there had been no national evaluation of
the adequacy of nurses’ educational preparation
for this role, and a lack of research investigation into
the post-qualification professional development
needs and experiences of nurse prescribers. Against
this backdrop, the study reported in this paper was
commissioned by the Policy Research Programme
at the Department of Health in England.7 This data was correct at the time that the research reported
here was conducted. From May 2005, qualified independent
nurse prescribers were able to prescribe from a list of around
240 POMs and all GSL and P medicines for around 110 clinicalBackground
The development of nurse prescribing
The prescribing of medicines by nurses in England
was piloted in the mid 1990s. Evaluation of the pilot
sites (Luker et al., 1997, 1998) showed favourable
findings across a range of indicators, from the per-
spectives of both patients and nurses. In 1999, thein the British National
rug Tariff.Department of Health introduced a national training
programme for some specialist community nurses
(those with a district nurse and/or health visitor
qualification) to train to prescribe dressings, appli-
ances and a limited number of medicines from the
Nurse Prescribers’ Formulary (NPF). These develop-
ments in nurse prescribing have taken place in all
four countries of the UK, with the devolved adminis-
trations in Scotland, Wales and Northern Ireland
guiding the precise pace and detail of education,
practice and policy on non-medical prescribing in
each country. This expansion of prescribing powers
to nurses also reflects international developments
in nurse prescribing: in theUnited States of America,
Canada, Sweden, Australia and New Zealand, legis-
lation enabling nurses to prescribe a limited number
ofmedicines has been in place for a number of years.
In Sweden for example, nurses working in primary
care and health care for older people have been able
to prescribe from a limited formulary of medicines
since the mid-1990s (Buchan and Calman, 2004).
(For an overview of international developments in
nurse prescribing, see Buchan and Calman, 2004.)
In England in 2002, nurse prescribing was
extended to cover not just those nurses with a dis-
trict nurse and/or health visitor qualification, but
also a wider range of nurses who, after successful
completion of a longer training programme, were
able to independently prescribe over 180 Prescrip-
tion Only Medicines (POMs), all General Sales List
(GSL) and Pharmacy (P) medicines for around 80
clinical conditions.7 Independent prescribing hasconditions listed in the Nurse Prescribers’ Extended Formulary
(NPEF). Since May 2006, nurse independent prescribers have
been able to prescribe all medicines from the British National
Formulary, with the exception of some controlled drugs.
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responsibility for the clinical assessment of the pa-
tient, establishing a diagnosis and the clinical man-
agement required, as well as responsibility for
prescribing where necessary, and the appropriate-
ness of any prescription’. (Department of Health,
2004). The training to become an Extended Formu-
lary Nurse Prescriber’ (EFNP) consisted of 25 days
taught content in a Higher Education Institution
(HEI), together with 12 days supervised practice
in the clinical setting with a doctor, known as a
supervising medical practitioner. EFNP was origi-
nally targeted at those nurses who were working
in roles where they were likely to be able to inde-
pendently complete an episode of care with the
acquisition of prescribing powers (Department of
Health, 2002). Entry to the programme was re-
stricted to those with at least three years experi-
ence after initial nurse registration, and those
who were able to study at degree level. The deliv-
ery of prescribing education programmes by HEIs is
based on curriculum requirements specified by the
NMC (2006). The specified knowledge areas re-
quired for an independent nurse prescribing role
are summarized as:
 Legislation that underpins prescribing.
 Team working principles and practice.
 Philosophy and psychology of prescribing.
 Up to date clinical and pharmaceutical
knowledge.
 Principles of drug dosage, side effects, reactions
and interactions.
 Communication, consent and concordance.
 Relationship of public health requirements to
prescribing.
 The Code of Professional Conduct applied to
prescribing.
 The lines of accountability at all levels for
prescribing.
 Drug abuse and the potential for misuse.
 Requirements of record keeping.
 Lines of communication.
 Leadership skills.
 Roles of other prescribers.
 Relationship of prescribers to pharmacists.
 Clinical governance requirements in prescribing
practice.
 Audit trails to inform prescribing practice.
Following successful completion of formal
assessment by the HEI, nurses registered their qual-
ification (V200) on the professional register with
the NMC.
Since 2003, both nurses and pharmacists have
been eligible to prescribe as supplementary pre-scribers, defined as a prescribing partnership be-
tween an independent prescriber (doctor or
dentist) and a supplementary prescriber to pre-
scribe within an agreed patient-specific Clinical
Management Plan (Department of Health, 2003).
Training for independent and supplementary
prescribing is now incorporated within a single
preparation programme of a minimum of 26 days
HEI-based learning and 12 days in practice with a
supervising medical practitioner. Nurses previously
qualified as EFNPs are able to undertake a two day
‘top up’ training, successful completion of which
enables them to practice as supplementary
prescribers.
The requirements for both nurses themselves
and the organizations who employ them in rela-
tion to continuing professional development
(CPD) are also laid out in policy guidelines on
non-medical prescribing. The Department of
Health (2004) guidelines stipulate that prescribers
will be expected to keep up-to-date with best
practice in the management of the conditions
for which they prescribe and the medicines in
the NPEF. Additionally, the guidelines state that
the employer should ensure that the practitioner
has access to relevant education and training pro-
vision. A framework of nurse prescribing compe-
tencies (National Prescribing Centre, 2001),
which builds on the NMC-specified competencies
for the nurse prescribing training curriculum is
also available as a tool to help both trainee and
qualified prescribers reflect on practice and to
identify their CPD needs.Research into nurse prescribers’ education
and professional development
A review of previous research into nurse prescribing
prior to the commencement of the study (see Latter
and Courtenay, 2004), highlighted a number of
education and CPD issues that warranted further
investigation. One recurring issue concerned inade-
quacies in the pharmacology knowledge of district
nurses and health visitors trained to prescribe in
the first wave of nurse prescribers in England, and
nurses’ need for further training in this area (While
and Rees, 1993; Otway, 2001, 2002; Sodha et al.,
2002a,b). Whilst not focusing specifically on evalu-
ating nurses’ educational preparation for a pre-
scribing role, both Luker et al. (1998) and Baird
(2001) identified that district nurse and health visi-
tor prescribers had initial anxiety about writing pre-
scriptions related to feelings of uncertainty about
making a correct diagnosis. This may have been
reflective of inadequate educational preparation
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prior clinical experience in formulating diagnoses.
However, the extent to which these problems have
been overcome since the introduction of a longer
training programme, with specified curriculum
requirements focusing on up to date clinical and
pharmaceutical knowledge, delivered to a wider
group of nurses with different roles and types of
clinical experience, had not been investigated prior
to the start of the study reported here.
Following the recent announcement of the fur-
ther extension of nurse and pharmacist prescrib-
ing powers, Avery and Pringle (2005, p. 1154)
comment that, ‘the current schemes for training
nurse and pharmacist prescribers are too short
to fully equip a professional for independent pre-
scribing practice. It is essential that additional
training, support and mentorship are available
after such programmes’. The need for further
education and professional development after
qualifying as a prescriber was also highlighted in
the literature review. In their earlier research
into district nurse and health visitor prescribing,
both Luker et al. (1997) and Brooks et al.
(2001) comment on nurses’ need for further train-
ing as expansions to the formulary are intro-
duced. Humphries and Green’s (2000) work on
district nurse and health visitor prescribers and
Bradley and Nolan’s (2004) research focused on
trainee EFNPs and found that keeping updated
and maintaining knowledge and skills were identi-
fied as potentially important issues in both
groups. Otway’s (2001, 2002) survey of more
experienced district nurse and health visitor pre-
scribers confirms the importance of on-going sup-
port and development for prescribing in practice,
and also sheds light on what is actually provided.
Otway conducted a questionnaire survey of 241
nurses in one NHS trust and subsequently inter-
viewed 12 nurse prescribers, some of whom had
up to three years’ experience of prescribing from
the original NPF for district nurses and health vis-
itors. She found that informal peer support
through working in teams provided a major source
of support, and that this often compensated for a
lack of more formal clinical supervision and men-
torship. Working in isolation in practice was found
to exert a negative influence on prescribing,
impacting on nurses’ confidence to prescribe.
Ninety five per cent of those surveyed reported
that they did not have a mentor when they first
began prescribing, although 48% did report access
to clinical supervision that included discussion of
their prescribing role. Limitations in access to
CPD for all prescribing professionals is also a con-
clusion drawn by Harris et al. (2004) followingtheir review of research into effective
prescribing.
The role of doctors in supporting and supervising
trainee and qualified nurse prescribers is also cru-
cial to ensure nurses are well prepared for their
prescribing practice. Despite the policy recommen-
dations on the role that doctors should play in the
education and supervision of EFINPs, the extent to
which doctors fulfill this role in the reality of prac-
tice was also under-researched at the time of this
study. District nurse and health visitor prescribers
in both Otway’s (2002) and Humphries and Green’s
(2000) studies reported that not all GPs were sup-
portive or aware of their prescribing role. How-
ever, in a more recent small scale study by Avery
et al. (2004), the satisfaction of facilitating nurse
prescribing was one of the benefits of nurse pre-
scribing reported by the purposive sample of 12
doctors interviewed. Nurse prescribers’ experi-
ences of supervision and support from doctors for
their prescribing role was an issue that was further
investigated in the study reported here.
Overall, the review of literature on nurse
prescribing highlighted an absence of research
investigating nurses’ experiences of educational
preparation and continuing professional develop-
ment for an extended formulary prescribing role.
Clearly, appropriate education and training and
CPD are essential for effective prescribing and
therefore research was required to evaluate the
effectiveness of educational preparation and CPD
to date for nurses prescribing independently in
practice.Study design
Aims and objectives
The overall aim of the study was to evaluate the
expansion of nurse independent prescribing in
England to inform future developments for pre-
scribing in nursing and other health professions.
This paper reports on the objectives of the study
that were concerned with evaluating the ade-
quacy of nurses’ educational preparation for inde-
pendent prescribing and their experiences of
continuing professional development as prescrib-
ers in practice.Design
A national survey of nurse independent prescribers
in England using a postal questionnaire comprised
the first phase of the study (for a detailed descrip-
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survey was conducted in 2003.Methods
A 54 item questionnaire was developed, contain-
ing both open and closed questions, to elicit data
on nurses’ views of key dimensions of independent
prescribing education and practice. The question-
naire was constructed following a review of the
literature (see above) which identified key issues
related to nurses’ educational preparation for pre-
scribing that required further investigation. The
draft questionnaire was also reviewed by expert
individuals with nurse prescribing education, pol-
icy and practice experience. Individuals who re-
viewed the draft questionnaire included expert
representatives from the National Prescribing Cen-
tre, The Royal College of Nursing, the Association
for Nurse Prescribing and nurse prescribing educa-
tion leads in Higher Education Institutions (HEIs).
A second draft was subsequently reviewed by
members of the research project’s Advisory Group
which included a recently qualified nurse pre-
scriber, doctors with an interest in nurse prescrib-
ing and Department of Health representatives.
The use of literature reviews and expert review
in the development of new data collection tools
are recognised methods of enhancing face and
content validity (DePoy and Gitlin, 1994). Written
and verbal feedback on the draft questionnaires
were incorporated into the design and content
of a revised questionnaire which was then sub-
jected to piloting.
The pilot study was conducted with 18 extended
formulary nurse prescribers registered in 2002/
2003 who were selected at random from the NMC
database. Questionnaire evaluation sheets were
also distributed to the pilot participants who were
asked to provide comments on the form and con-
tent of the questionnaire and to identify any ques-
tions that were ambiguous or unclear. Twelve
questionnaires (67%) were returned, together with
10 (56%) evaluation sheets. The piloting process
confirmed the feasibility of using the questionnaire
to ascertain nurse prescribers’ views on a broad
range of education and practice experiences. The
data collected from the pilot study also confirmed
the questionnaire’s face and content validity in
obtaining nurses’ views on their educational prepa-
ration for prescribing and their experiences of CPD.
Minor modifications were made following piloting,
for example, a filter question was included at the
beginning of the questionnaire for those who re-
ported that they were not using their prescribingqualification at the time that the survey was
conducted.
The questionnaire was distributed by post to the
sample of nurse prescribers by the NMC on behalf
of the research team. The nurse prescribers there-
fore remained anonymous to the research team un-
less they chose to disclose their identity on their
return questionnaire. A covering letter explaining
the purpose of the study, and outlining how ano-
nymity and confidentiality of participants would
be protected, was included with the questionnaire,
together with a stamped addressed envelope for
returning the questionnaire directly to the research
team. A second mailing was sent to non-responders
by the NMC approximately 4–6 weeks after the first
mailing.
The final version of the questionnaire used in the
main study comprised three sections: (1) Experi-
ences before the EFNP course. (2) Experiences dur-
ing the EFNP course. (3) Experiences after the EFNP
course, including sub-sections on ‘views on knowl-
edge and competencies’ and ‘views on support and
continuing professional development’. The findings
reported below are those from the questionnaire
items focused on educational experiences and
CPD in Sections 2 and 3 of the questionnaire.Sample
Four hundred nurse prescribers for the national sur-
vey were randomly selected from the NMC’s data-
base of approximately 500 nurse prescriber
registrations for 2002/early 2003 in England. The
period of 2002/early 2003 was chosen so as to en-
sure that, at the time of the survey, the sample
of nurse prescribers targeted would have had at
least six months of prescribing in practice. It was
envisaged that this would enable nurse prescribers
to meaningfully reflect on their educational prepa-
ration, its adequacy for on-going prescribing prac-
tice and would also allow them the opportunity to
reflect on their continuing professional develop-
ment needs and experiences.Ethical considerations
During the course of the study, the Royal College of
Nursing’s (1998) research ethics guidelines were
utilised as a framework to ensure that ethical is-
sues were properly addressed by the research
team. This included adequately informing all par-
ticipants about the details of the research study,
and using procedures to anonymise the data whilst
stored and in any reported findings, and keeping
the data secure and confidential.
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For responses to open ended questionnaire items,
coding frameworks were devised inductively from
the data, and a process of content analysis applied
that included numerical quantification of responses
where appropriate. Descriptive statistics were pro-
duced from analysis of the questionnaire data de-
rived from both open ended and fixed choice
items using Statistical Package for the Social Sci-
ences (SPSS) Version 12.0 software.Results
Sample characteristics
Of the 400 questionnaires distributed to qualified
nurse independent prescribers, 285 (71%) were re-
turned. Of these, 39 (14%) were not prescribing
at the time of the survey; therefore 246 question-
naires were available for analysis. Respondents
were working in senior nursing roles. The most
common roles were: nurse practitioners (56%
138/246), practice nurses (10% 25/246), sister/
team lead positions (7.5% 19/246) and nurse spe-
cialist roles (6.5% 16/246). The sample of nurses
in the survey also had a comparatively high level
of academic qualifications: 60% (147/246) held a
first degree, and 21% (51/246) had obtained a Mas-
ters level qualification. The most commonly stated
area of practice was general practice/primary care
(54% 135/246), with smaller proportions also spec-
ifying a range of other service delivery roles lo-
cated in primary care, such as walk-in centres
(4.5% 11/246), family planning (3% 7/246) and min-
or injuries units (2% 6/246). Other clinical areas
that respondents were working in included Acci-54
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care (3% 8/246).
Experiences during the EFINP course
Fig. 1 outlines nurses’ views on the extent to which
the 25 days HEI-based education programme met
their needs as trainee nurse prescribers.
Fig. 1 illustrates that the majority of the sam-
ple considered that the taught programme met
their needs, either ‘to some extent’ (61% 151/
245), or ‘completely’ (22% 54/245), although a
small minority were less satisfied with the taught
programme as a preparation for prescribing. This
finding concerning the adequacy of educational
preparation was reinforced by responses to a
Likert statement: ‘I believe the EFINP course
prepared me for my role as an EFINP’. 22%
(54/246) strongly agreed, 48% (119/246) agreed,
18% (44/246) were uncertain, 9% (22/246) dis-
agreed and 2% (4/246) strongly disagreed with
this statement.
Nurse prescribers were asked to specify the
three subjects most commonly studied during pri-
vate/self-directed study. Table 1 shows the re-
sponses to this item. Over three quarters of
those who responded (84% 192/228) identified
pharmacology as one of the top three most com-
monly studied subjects. Polypharmacy was identi-
fied by 23.5% (54/228) of the sample, legal and
ethical issues by 23% (53/228), principles of pre-
scribing by 22.5% (52/228) and anatomy and phys-
iology/pathophysiology by 20.5% (47/228) of the
sample.
Nurse prescribers were also asked about the
amount of support they received from their super-
vising medical practitioner. Almost half (47% 116/
246) reported that they had received ‘more than’1
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Table 3 Skills/knowledge needed for practice and
not covered by EFNP course
Skills and knowledgea No. (%) of
respondents
(n = 119)
Pharmacology 46 (39%)
Advanced clinical skills 38 (32%)
Physical assessments 16 (13%)
Skills related to practice area 14 (9%)
More information on the
formulary
10 (8%)
a Top five responses only.
Table 1 Topics reported as amongst the top three
most commonly studied during private/self-directed
study
Topics No. (%) of
respondents
(n = 228)
Pharmacology 192 (84%)
Polypharmacy 54 (23.5%)
Legal and ethical issues 53 (23%)
Principles of prescribing
(knowledge)
52 (22.5%)
A&P/pathophysiology 47 (20.5%)
Ailments/conditions 40 (17.5%)
Other (personal development) 40 (17.5%)
Research (nurse prescribing) 39 (17%)
BNF/medicines/NPEF/MIMS 34 (15%)
Prescribing related to own
practice
34 (15%)
Clinical assessment/history
taking
30 (13%)
Compliance/concordance 4 (1.5%)
Table 2 Level of satisfaction with supervising med-
ical practitioner support
No. (%) of respondents
(n = 246)
Very satisfactory 77 (31%)
Satisfactory 126 (51%)
Unsatisfactory 31 (13%)
Very unsatisfactory 10 (4%)
No response 2 (1%)
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receiving ‘exactly’ 12 days and 23% (56/246) re-
ported receiving ‘less than’ the specified 12 days
support from their supervising medical practi-
tioner. Table 2 shows the nurse prescribers’ satis-
faction with the amount of medical practitioner
support that they had received during their prep-
aration to become independent prescribers. This
indicates that the majority (82% 203/246) had
found the level of support ‘satisfactory’ or ‘very
satisfactory’, whilst a minority (17% 41/246) were
not satisfied with the support from their supervis-
ing medical practitioner.
Eighty five per cent (208) of the sample also
responded to an item asking for comments about
the quality of the medical practitioner support
received. Sixty four per cent (134/208) of these
comments were positive: supervising medical prac-
titioners were identified as ‘supportive’, ‘excel-
lent’, ‘non-threatening’ and ‘encouraging andenthusiastic’. However, 21% (44/208) of responses
identified the work commitments of their supervis-
ing doctors as prohibitive. A minority (14% 30/208)
of comments were also focused on other negative
experiences, such as poor teaching skills and lack
of support generally.
Respondents were invited to provide comments
on the form of the support that they had received
from their supervising medical practitioner.
Ninety per cent (221) of the sample responded
to this questionnaire item. Information was given
on the method of delivery of their support as well
as content. Methods most frequently identified
included:
 observation of each other’s surgeries (44% 97/
221),
 discussion of patient’s interaction/assessment/
treatment/diagnosis (30% 67/221),
 case study analysis (25% 55/221),
 tutorials/teaching (25% 55/221).
In regard to the content of medical practitioner
support, comments tended to be varied but some
dominant themes emerged. These included:
 safe/guided prescribing decisions (56% 123/221),
 history taking/examination skills/diagnostic
skills (40% 88/221),
 aspects of pharmacology (14% 30/221),
 reflective practice (12% 26/221).
Respondents were asked to indicate whether
they had received any other support in addition
to their supervising medical practitioner whilst
undertaking the EFNP course. Sixty three per cent
(156/246) of the sample stated that they had re-
ceived other support, with 35% (87/246) reporting
that this was not the case. Those respondents
who had reported receiving other support in prac-
Table 4 Are nurse prescribers able to maintain National Prescribing Centre (2001) competencies in practice? (n = 246)
Statement Strongly agree Agree Uncertain Disagree Strongly disagree No answer
I have up to date clinical knowledge 53% (n = 131) 46% (n = 113) 1% (n = 2) 0 0 0
I have up to date pharmacological
knowledge
39.5% (n = 97) 55.5% (n = 137) 5 (n = 12) 0 0 0
I am able to make a diagnosis and
generate treatment options
55% (n = 135) 44% (n = 109) 1% (n = 2) 0 0 0
I always follow up treatment when
appropriate
58% (n = 144) 40% (n = 98) 1% (n = 2) 0.5% (n = 1) 0 0.5% (n = 1)
I am able to establish a relationship
with patients based on trust and
respect
67.5% (n = 166) 31.5% (n = 78) 1% (n = 2) 0 0 0
I see patients as partners in the
consultation
72% (n = 177) 27% (n = 66) 1% (n = 3) 0 0 0
I apply the principles of concordance 66% (n = 163) 33% (n = 81) 1% (n = 2) 0 0 0
I work within professional and
organisational standards
73% (n = 180) 26.5% (n = 65) 0.5% (n = 1) 0 0 0
I take personal responsibility for
prescribing decisions
78.5% (n = 193) 21.5% (n = 53) 0 0 0 0
I actively participate in the review
and development of prescribing
practice
45% (n = 111) 44% (n = 108) 7.5% (n = 19) 2.5% (n = 6) 0 1% (n = 2)
I understand and work within local
and national policies
52.5% (n = 129) 45.5% (n = 112) 2% (n = 5) 0 0 0
I know how to access relevant
information
55% (n = 135) 42% (n = 104) 2% (n = 5) 0 0 1% (n = 2)
I can critically appraise and apply
information in practice
46.5% (n = 114) 48.5% (n = 119) 5% (n = 13) 0 0 0
I work in partnership with colleagues
to benefit patients
67% (n = 164) 32% (n = 79) 1% (n = 3) 0 0 0
I an self-aware and confident in my
ability as a prescriber
55.5% (n = 137) 42% (n = 103) 2.5% (n = 6) 0 0 0
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Table 5 Nurse prescribers’ CPD needs relating to
prescribing
Current professional
development needsa
No. (%) of
responses
(n = 182)
Regular updates 73 (40%)
Training for formulary expansion 25 (13.5%)
CPD related to area of practice 15 (8%)
Evaluating nurse prescribers’ education and continuing professional development 693tice were asked to provide further details on the
form that this support had taken. Fifty-nine per
cent (145/246) of the total number of respondents
gave additional comments relating to other support
received during the EFNP course. Providers of sup-
port were identified as pharmacists (42% 104/246);
peer support/other nurses (35% 86/246); other
medics (11% 28/246); existing nurse prescribers/
nurse mentor (4% 10/246).Local prescribing group meeting 14 (7.5%)
a Top four responses only.Experiences after the EFINP course: views
on knowledge and competencies
Respondents were asked whether there were any
skills and knowledge needed in their prescribing
practice that had not been covered by the EFNP
course. Over half of respondents (52% 127/246) felt
that the course had covered the skills and knowl-
edge required for practice. However, 40% (99/
246) stated that there were areas of skills and
knowledge needed in practice which had not been
covered by the course.
In total 48% (119/246) of respondents provided
further comments on the skills and knowledge they
considered not fully covered by the course. While
these produced a wide variety of opinion, five key
themes emerged including: pharmacology issues;
advanced clinical skills/examination skills/diagnos-
tic skills; physical assessments; skills related to
practice; information on formulary/BNF; and legal
ethical issues (see Table 3).
Respondents were asked to consider a number of
statements reflecting the prescribing competen-
cies developed by the National Prescribing Centre
(2001) and the extent to which they felt they had
been able to maintain these competencies in their
area of practice since qualifying as an EFNP. Find-
ings are shown in Table 4.
Table 4 highlights that the vast majority of
nurses agreed that they had been able to maintain
these competencies in practice. For example, 99%
(244/246) agreed or strongly agreed that they had
up-to-date clinical knowledge, and 95% (234/246)
agreed or strongly agreed that they had up-to-date
pharmacological knowledge.
With regard to the competency of being able to
diagnose and generate treatment options (as shown
in Table 4), respondents were asked elsewhere in
the questionnaire to respond to a related Likert
statement: ‘I fear making an incorrect diagnosis’.
Analysis showed that 23.5% (58/246) agreed and
4.5% (11/246) strongly agreed with the statement;
46% (113/246) disagreed with this statement, 9%
(22/246) strongly disagreed and 16% (39/246) re-
sponded that they were ‘uncertain’.Experiences after the EFINP course: views
on support and continuing professional
development
Sixty two per cent (152/246) of respondents re-
sponded ‘yes’, they were currently receiving sup-
port or supervision for their role as an extended
formulary nurse prescriber; 37% (92/246) reported
that they were not. Those nurse prescribers who
reported receiving support/supervision were also
asked to identify who provided this. Of those who
specified, the majority (67% 102/152) reported
that this was provided by medical colleagues, 39%
(59/152) reported support from other nurses, 24%
(37/152) specified other nurse prescribers and
pharmacists were cited as sources of support by
28% (43/152).
Nurse prescribers in the survey had been qualified
as independent prescribers for between 6 and 12
months approximately. Nurses were asked whether
they had undertaken any formal CPD relevant to
their needs as prescribers since qualifying as a pre-
scriber: 52% (127/246) reported that they had done
so, and 48% (118/246) reported that they had not.
The most common forms of CPD cited by respon-
dents were supplementary prescribing ‘top up’
training (37%45/121), andevents such as prescribing
workshops/conferences/study days (20% 24/121).
Greater numbers of respondents reported that
they were ‘able to engage in informal CPD such
as private study and reading journals regularly’:
95% (233/246) responded ‘yes’ to this item, and
only 0.5% (1/246) responded ‘no’.
Fifty seven per cent (139/246) of the sample re-
ported that they had ‘current CPD needs in relation
to nurse prescribing’, 28% (68/246) reported that
they did not, and 8% (20/246) answered that they
did not know. The five most frequently cited needs
are outlined in Table 5.
As Table 5 indicates, many responses were non-
specific about the content of the CPD required
(‘regular updates’), whilst others were clear that
they needed development concerned with the
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medicines, or CPD related to their area of prescrib-
ing practice.Discussion
The findings from this national survey highlight a
number of issues concerning the educational prep-
aration and on-going professional development of
nurse independent prescribers that warrant discus-
sion in the light of the current health care policy
and practice context.
The initial education programme of 25 HEI-based
taught days was perceived to be satisfactory in
meeting needs, at least to some extent, by the
majority of the sample. This finding is encouraging,
and suggests that the length, format and content of
NMC approved programmes delivered by a range of
HEIs in England enables nurse prescribers to be
adequately prepared for practice. Nevertheless,
the reasons why a smaller minority of the sample
did not consider that the course met their needs
deserves further investigation. Some explanations
may be found in other findings from the question-
naire (see below).
Previous research into the first wave of nurse
prescribing in the United Kingdom had indicated
that some nurses’ pharmacology knowledge was
inadequate for a prescribing role (While and Rees,
1993; Otway, 2001, 2002; Sodha et al., 2002a,b).
In this study, pharmacology was the topic most
prevalently studied as part of self-directed study
by nurses in this survey, and was also the most fre-
quently cited area of knowledge that was per-
ceived not to have been covered sufficiently (in
relation to knowledge needed for practice) within
the initial preparatory programme of learning. This
may be linked to the finding that approximately
16% (39/246) of the sample considered that the
course had not meet their needs. It should be borne
in mind that some of the nurses in this survey
undertook education programmes over a three
month period (as originally specified by the NMC),
and not the currently recommended period of up
to six months, and this may have led to respondents
viewing the pharmacology content of programmes
in this way. Although these findings may suggest
deficiencies in nurses’ pharmacology knowledge,
it is significant that the vast majority of nurse pre-
scribers in this survey, who had been qualified
between 6 and 12 months approximately, consid-
ered that they had up-to-date pharmacological
knowledge, and also reported that they were self-
aware and confident in their prescribing practice.Whilst inadequacies in nurse prescribers’ pharma-
cology knowledge cannot be fully ruled out, due
to the limitations of self-report data, findings from
observation of nurses’ prescribing practice re-
ported elsewhere (Latter et al., 2005) indicated
that there was little cause for concern about the
clinical appropriateness of nurses’ prescribing
decisions, suggesting that EFNPs’ levels of pharma-
cology knowledge were adequate for the medicines
they are currently prescribing. It is possible that
the nurse prescribers’ emphasis on pharmacology
learning reported in this study is a reflection of dili-
gence and motivation to learn, rather than a reflec-
tion of inadequate knowledge per se.
The findings from this study also highlighted that
the vast majority of nurse independent prescribers
surveyed feel able to diagnose and generate treat-
ment options and take personal responsibility for
prescribing decisions. Whilst some anxiety about
making an incorrect diagnosis was reported by a
fairly small minority of the sample here, these re-
ported competencies are in contrast to previous re-
search (Luker et al., 1998; Baird, 2001) into district
nurse and health visitor prescribers’ feelings about
their prescribing practice. It is likely that the posi-
tive findings of the study reported here are a
reflection of the characteristics of the nurse pre-
scribers in this study. Most were in senior nursing
roles, such as nurse practitioners, and it is there-
fore likely that many of these nurses had previous
clinical experience of diagnosis and a high degree
of responsibility in their practice.
The finding that most nurses had received 12
days or more supervision from their designated
supervising medical practitioner as part of their
educational preparation for prescribing, and re-
ported fairly high levels of satisfaction about this
experience, with many positive comments about
their medical mentors, is also encouraging. Many
also continued to receive support and supervision
for their prescribing practice from doctors after
qualifying as prescribers. This finding provides evi-
dence that doctors are actively engaged in super-
vising and supporting both trainee and qualified
nurse prescribers and helps to counter claims
(Baird, 2001) and previous research into district
nurses’ and health visitors’ views of prescribing
(Humphries and Green, 2000; Otway, 2002), which
indicated that doctors were unaware or unsupport-
ive of nurses’ prescribing roles.
The positive findings concerning nurses’ experi-
ences of initial preparation for independent pre-
scribing should however be viewed in light of the
sample characteristics of this cohort of nurse pre-
scribers. That is, as a group, they were working in
senior clinical roles, and were well qualified aca-
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knowledge and experience levels prior to embark-
ing on the prescribing training programme. The
majority of the sample were working in primary
care in roles such as nurse practitioners and prac-
tice nurses. This indicates that these nurses were
likely to be working in primary health care teams,
with their designated supervising medical practi-
tioner as part of such teams. Therefore, establish-
ing working relationships and access to supervision
time may have been facilitated by existing rela-
tionships with supervising doctors and/or ready
on-site access to them. As the roll out of non-med-
ical prescribing continues, to more nurses, pharma-
cists and allied health care professionals, levels of
academic knowledge and clinical experiences of
trainee prescribers are likely to become more di-
verse. A recent survey (Bradley et al., 2005) of 91
nurses training to be prescribers in 2003/4 in one
University in England confirms this. Bradley et al
found a lower prevalence of first degree (31%)
and postgraduate degree (14%) qualifications in
their sample in comparison to the qualifications
of the sample in the study reported here. Access
to supervising doctors may also become more diffi-
cult as both numbers of professionals requiring
supervision increases, and as trainee prescribers in-
clude those working outwith explicit team struc-
tures (such as nurses working across GP practices
in community specialist roles). The prohibitive
work commitments of doctors creating difficulties
for supervision was reported by some nurses in this
study, and this may be compounded as the numbers
and types of non-medical prescriber trainees in-
crease in line with government policy.
The vast majority of nurses in this study re-
ported that they were able to maintain a range of
prescribing competencies in practice. The majority
of nurses were acting in accordance with the
Department of Health (2004) on CPD and were
engaging in self-directed activities to maintain pre-
scribing knowledge and skills. Two thirds were also
receiving support and supervision for their pre-
scribing practice from other health care profes-
sionals with whom they worked, including
doctors, nurses and, to a lesser extent, pharma-
cists. Such activities may have been the main route
by which these nurse prescribers were able to
maintain their prescribing competencies, as access
to formal CPD was reported as less universal, and,
for many, CPD had taken the form of supplemen-
tary prescribing training, and was not therefore
indicative of on-going CPD opportunities. Lack of
access to CPD for prescribing nurses is highlighted
by previous research into nurse prescribing (Otway,
2002), and is of concern, given the Department ofHealth (2004) guidance on the CPD responsibilities
of employers to provide access to education and
training and also the importance that nurses place
on it (Humphries and Green, 2000; Bradley and No-
lan, 2004) in order to ensure safe and effective pre-
scribing practice. Findings from the study reported
elsewhere (Latter et al., 2005) highlighted that
organizational supports for nurses who are pre-
scribing may be lacking in a number of respects:
some nurses in primary care still do not have access
to computer-generated scripts which they perceive
to be limiting to their prescribing practice, access
to Prescription Analysis and Costs Data (PACT) data
for nurses working in primary care in this study was
also far from universal. The limited access to for-
mal CPD highlighted in this study may have been
a function of the timing of the survey: that is,
the majority of the nurses in the sample had only
been qualified for between 6 and 12 months
approximately, and it may be that their needs for
and consequent access to CPD will increase as time
goes on. However, the findings do suggest that
there is no room for complacency and that action
is required at an organizational level, through for
example, the leadership and direction of nurse pre-
scribing leads in Strategic Health Authorities, PCTs
and NHS Trusts to ensure that nurse prescribers in
employing trusts are able to regularly update the
knowledge and skills that should underpin safe
and effective prescribing practice.Conclusion
This first national survey of the education and pro-
fessional development experiences of nurse inde-
pendent prescribers in England provides evidence
which highlights areas in which national policy is
working well, and also points up issues which may
need addressing as the roll out of nurse prescribing
continues. In evaluating the current model of edu-
cational preparation and forms of CPD for nurse
prescribers in England, the findings highlight char-
acteristics of programmes that health care policy
makers and nurse educationalists internationally
may wish to consider in developing and refining
nurse prescriber education programmes in their
respective countries across the world.Study limitations
This paper reports findings that are based on
nurses’ self-reported views of their prescribing
education and practice. As indicated above, the
findings also need to be viewed in light of the
696 S. Latter et al.timing of the survey: the sample targeted nurse
prescribers who had qualified within approximately
18 months of the introduction of independent
nurse prescribing, and this may have resulted in
particular educational experiences that may or
may not be typical of later cohorts of trainee nurse
prescribers. Additionally, nurses in this survey
had only been qualified for between 6 and 12
months approximately at the time of the survey,
and this may also have influenced the extent to
which they had experienced access to CPD opportu-
nities. Further research into on-going education
and CPD experiences of non-medical prescribers
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